Founded by scientists from the pharmaceutical, biotech and CRO industries, ANS Biotech is a world-renowned resource providing in vivo services for the development and evaluation of new analgesic treatments.
Exclusively focused in pain, we have delivered efficacy and safety profiles of hundreds of drug candidates for our clients, while constantly developing new models and methods for their future use.
ALGOGram™ 2.0 offers a dual focus on efficacy and safety; an invaluable advantage for researchers looking to understand both the therapeutic effects and potential adverse impacts of compounds in early-stage drug development.
Combined together, ALGOGram™ 2.0 serves as a powerful “GO/NO GO” decision tool. This global fingerprint offers clear, actionable insights, minimizing the risk of progressing with ineffective compounds.
We use cookies to guarantee you the best experience on our site, to make statistics, to offer you third-party video services like Youtube, social network sharing. By clicking on validate and closing this banner, you accept the deposit of cookies.AcceptRefuseLearn more
You may revoke your consent at any time by using the "Revoke Consent" button.Manage my cookies
